Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oluf Andersen

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Lakartidningen|May 10, 2002
[Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries]Oluf Andersen
Brain : a Journal of Neurology|June 30, 2010
Predicting a window of therapeutic opportunity in multiple sclerosisOluf Andersen
Nature Reviews. Neurology|September 12, 2012
Disease mechanisms in MS: phases of disease improvement unrelated to relapsesOluf Andersen
Ugeskrift for Laeger|August 27, 2003
[Ornithosis--an overlooked cause of atypical pneumonia]Peter Oluf Andersen
Lakartidningen|April 21, 2010
[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far]Rayomand Press, Oluf Andersen
Neurology|April 18, 2020
Predictive MS risk factors and axonal disintegrationOluf Andersen, Massimo Filippi
Neuroepidemiology|October 2, 2004
No major birth order effect on the risk of multiple sclerosisCecilia Ahlgren, Oluf Andersen
Lakartidningen|June 28, 2012
[Inflammatory polyneuropathies can be treated successfully]Rayomand Press, Håkan Askmark, Oluf Andersen
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosisMaja Eriksson, Oluf Andersen, Björn Runmarker
Infection and Drug Resistance|July 19, 2023
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous SystemOluf Andersen, Ingemar Ernberg, Anna Karin Hedström
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Lakartidningen|May 10, 2002
[Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries]Oluf Andersen
Brain : a Journal of Neurology|June 30, 2010
Predicting a window of therapeutic opportunity in multiple sclerosisOluf Andersen
Nature Reviews. Neurology|September 12, 2012
Disease mechanisms in MS: phases of disease improvement unrelated to relapsesOluf Andersen
Ugeskrift for Laeger|August 27, 2003
[Ornithosis--an overlooked cause of atypical pneumonia]Peter Oluf Andersen
Lakartidningen|April 21, 2010
[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far]Rayomand Press, Oluf Andersen
Neurology|April 18, 2020
Predictive MS risk factors and axonal disintegrationOluf Andersen, Massimo Filippi
Neuroepidemiology|October 2, 2004
No major birth order effect on the risk of multiple sclerosisCecilia Ahlgren, Oluf Andersen
Lakartidningen|June 28, 2012
[Inflammatory polyneuropathies can be treated successfully]Rayomand Press, Håkan Askmark, Oluf Andersen
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosisMaja Eriksson, Oluf Andersen, Björn Runmarker
Infection and Drug Resistance|July 19, 2023
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous SystemOluf Andersen, Ingemar Ernberg, Anna Karin Hedström
Pageof 7